People are eligible for lung cancer screening if they are between 50 and 80, smoked or have quit within the past 15 years and have a 20 pack-year or more smoking history.

SEER data show that small cell lung cancer (SCLS) incidence has steadily declined due to reduced smoking rates, but survival outcomes have seen only minimal improvement, underscoring the need for more ...

A recent study found that structured cessation programs improve quit rates among lung cancer screening participants. How can physicians leverage this?

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

Discover how explainable AI (xAI) and real-world data (RWD) improve clinical decision-making in oncology by identifying key prognostic markers across multiple cancer types.

Many people at risk for lung cancer including current and former smokers undergo regular screening for lung cancer with a low ...

The following is a summary of “Brachytherapy Seed Placement by Robotic Bronchoscopy with Cone-Beam CT Guidance for Peripheral ...

Onc.AI presented results at the Society for Immunotherapy of Cancer (SITC), showcasing a multi-institutional study demonstrating that Serial CTRS improved the prediction of overall survival for ...

Did you know that Hungary has the worst cancer survival rates in the EU? Check out our article to find out why Hungary has ...

BENGALURU: When 52-year-old Rahul (name altered), a non-smoker and fitness enthusiast, started experiencing a persistent ...

H5N1 continues to devastate egg-laying chickens in the U.S. But experts say eggs are safe to eat, especially if you cook them ...

NEW YORK – UK-based startup Oxford Cancer Analytics is using the $11 million it has raised in a Series A financing to further develop and commercialize its protein-based lung cancer screening assay.